Ravenbhel Healthcare
Your dependable formulation partner.
Certifications claimed: WHO- Country
- India
- Region
- Punjab
- Website
- www.ravenbhel.com
About the
partner
Ravenbhel Healthcare Pvt. Ltd. is an Indian formulation company working across contract development, scale-up and commercial manufacture, with its head office in Amritsar, Punjab.
The business traces its origins to 1981 and to Macmillon Pharmaceutical Ltd. The group has since added Ravenbhel Pharmaceutical Pvt. Ltd. in 2001, Ravenbhel Healthcare Pvt. Ltd. in 2004, Ravenmac Pharmaceuticals Pvt. Ltd. in 2010, Oswin Pharmaceutical in 2013 and Ravenbhel Biotech in 2014.
Manufacturing is organised across three units. Unit I serves domestic contract manufacturing and rest-of-world markets, Unit II — Ravenbhel Biotech — serves regulated markets, and Unit III — Macmillon Pharma — is dedicated to hormones.
The catalogue runs across gynaecology, anti-diabetic, pain management, ortho, gastro, neuro, general and supplement ranges. The gynaecology range is hormone-led — dydrogesterone, progesterone, norethisterone, medroxyprogesterone acetate, allylestrenol, levonorgestrel and hydroxyprogesterone caproate — which is the capability most directly relevant to Zafieon Pharma's portfolio.
The company states that it has sponsored and conducted six Phase IV clinical trials and twenty-six bioequivalence studies, and that it maintains in-house research and development alongside its manufacturing.
- Naresh MahajanFounder
- Sahil MahajanSuccessor
Manufacturing
capabilities
Quality &
regulatory
WHO
WHO
WHO-GMP certificates are issued by national or state drug regulators applying WHO Good Manufacturing Practice guidelines. The WHO does not itself certify manufacturers.
Certifications shown are held by the manufacturing partner named, as stated in that partner's documentation. They are not certifications held by Zafieon Pharma.
Regulatory registrations
6 stated by the partner
Ethiopian Food & Drug Authority (EFDA)
Food and Drug Administration, Philippines
Direction de la Pharmacie et du Medicament (DPM)
Pharmacy and Poisons Board, Ministry of Health, Republic of Kenya
National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria
Ministry of Health & Prevention, United Arab EmiratesThese are national regulatory registrations and approvals held by Ravenbhel Healthcare, as printed in its own documentation. They are not certifications, they are not held by Zafieon Pharma, and they say nothing about the registration status of any Zafieon Pharma product in those markets.
Sterile injectables and R&D facility
To be operated by Biovonic Healthcare Pvt. Ltd..
Ravenbhel Healthcare announces this facility and these capacities as upcoming in its own documentation. They are planned, not installed, and no Zafieon Pharma product is manufactured there.
Documented sites
4 sitesRavenbhel Healthcare Pvt. Ltd.
Amritsar, Punjab
Unit I — domestic contract manufacturing and ROW marketsRavenbhel Biotech
Amritsar, Punjab
Unit II — regulated marketsMacmillon Pharma
Amritsar, Punjab
Unit III — dedicated to hormonesHead office
17/2 Kennedy Avenue, Amritsar – 143 001, Punjab
Export markets
27 stated by the partnerThe company is named Ravenbhel Healthcare Pvt. Ltd. throughout its own product catalogue. It appears as “Revenbhel” in Zafieon’s brief; the brochure spelling is used here.
The catalogue states that Unit III is compliant with USFDA, UK MHRA and PIC/S requirements. That is the partner’s own statement of the standard the unit is built to — not evidence of an inspection outcome or an approval held — and no regulator’s emblem is shown against it.
The regulatory registrations listed are those printed on the partner’s certifications page. They are market registrations held by Ravenbhel, and they say nothing about the registration status of any Zafieon Pharma product.
The sterile injectables and R&D facility is announced in the catalogue as upcoming, under Biovonic Healthcare Pvt. Ltd. The capacities stated are planned, not installed.
The catalogue states forty-three years of experience and dates the group’s origins to 1981. The figure is reproduced as printed.
Companies Ravenbhel Healthcare manufactures for
The companies listed below are stated, in this partner's own corporate documentation, to be companies it manufactures for. They are the manufacturing partner's relationships. Zafieon Pharma neither owns these brands nor claims any commercial relationship with them.
Company names are reproduced as printed in Ravenbhel Healthcare's corporate documentation and remain the property of their respective owners. Their appearance here indicates a stated manufacturing relationship with Ravenbhel Healthcare only.